瑞典全国重症肌无力队列中患者报告的症状严重程度:GEMG研究横断面分析
该研究基于瑞典GEMG研究,纳入1077例重症肌无力患者,使用MG-ADL评估症状严重程度。结果显示26%的患者MG-ADL评分为0分,而47%的患者MG-ADL≥3分,提示症状状态不理想。较高的MG-ADL评分与女性、肥胖和诊断延迟相关,与高教育程度呈负相关。
要点
- 近半数重症肌无力患者MG-ADL≥3分,症状状态不理想。
- 女性、肥胖和诊断延迟与较高的MG-ADL评分相关。
- 高教育程度与较低的MG-ADL评分相关。
核心结论
- 在瑞典全国重症肌无力队列中,近半数患者报告的症状状态不理想,提示需要改进治疗选择。
研究设计与样本
- 横断面患病率队列研究,纳入瑞典GEMG研究中1077例重症肌无力患者,应答率74%。
主要发现
- MG-ADL评分范围为0至18分,26%的患者评分为0分。
- 较高的MG-ADL评分与女性(OR 1.62,p adj=0.017)、肥胖(OR 1.72,p adj=0.013)和诊断延迟(OR 1.69,p adj=0.008)相关。
- 较高的MG-ADL评分与高教育程度呈负相关(OR 0.59,p adj=0.02)。
- MG-ADL评分与纳入时年龄、疾病亚型或疾病病程无关。
- 47%的患者MG-ADL≥3分,对应症状状态不理想。
临床怎么用
- 临床中应关注重症肌无力患者的症状负担,尤其是女性、肥胖和诊断延迟的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To describe myasthenia gravis activities of daily living (MG-ADL) in relation to clinical characteristics in a large Swedish nationwide cohort. METHODS: In a cross-sectional prevalence cohort study, the Genes and Environment in Myasthenia Gravis study, performed from November 2018 through August 2019, patients with myasthenia gravis (MG) were invited to submit an extensive 106-item life environment questionnaire, including the MG-ADL score. Patients were classified into early-onset MG (EOMG, <50 years), late-onset MG (LOMG, ≥50 years), or thymoma-associated MG (TAMG). Comparisons of disease-specific characteristics were made between subgroups, sexes, and different MG-ADL scores. RESULTS: A total of 1,077 patients were included, yielding a 74% response rate: 505 (47%) were classified as EOMG, 520 (48%) LOMG, and 45 (4%) TAMG. Mean age at inclusion was 64.3 years (SD 15.7) and mean disease duration was 14.6 years (SD 14.0). Complete MG-ADL scores (n = 1,035) ranged from 0p to 18p, where 26% reported a score of 0p. Higher MG-ADL scores were associated with female sex, obesity, and diagnostic delay (odds ratio [OR] 1.62, 1.72, and 1.69; p adj = 0.017, 0.013, and 0.008) and inversely correlated with high educational attainment (OR 0.59; p adj = 0.02), but not with age at inclusion, disease subtype, or disease duration. Almost half of the population (47%) reported MG-ADL ≥3p, corresponding to an unsatisfactory symptom state. DISCUSSION: In this nationwide study, comprising more than 40% of the prevalent MG population in Sweden, almost half of the patients reported current disease symptoms associated with an unsatisfactory symptom state, indicating the need for improved treatment options.
引用
- Petersson M, Feresiadou A, Jons D, et al. Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study. Neurology. 2021. PMID: 34376512. doi:10.1212/WNL.0000000000012604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。